Publication in Select Science

Editorial Article: Early detection of prostate cancer through game-changing molecular biomarkers
Dr. Nallasivam Palanisamy, Henry Ford Cancer Institute, discusses his discovery of the first pseudogene-associated recurrent gene fusion in cancer and the potential for this robust biomarker for application beyond prostate cancer

Prostate Cancer Biomarker

https://www.selectscience.net/editorial-articles/early-detection-of-prostate-cancer-through-game-changing-molecular-biomarkers/?artID=52161